Drug Development for Stroke

Stroke affects many people worldwide. However, due to the complexity of stroke and the very short treatment window, there are no effective therapies for stroke. Ace Therapeutics has more than a decade of research experience in the stroke field. Based on our extensive research experience and advanced technology platform, we are committed to facilitating progress in stroke drug development and helping you with your stroke drug development research.

Small Molecule for Stroke

Small Molecule for Stroke

Small molecule drugs have many unparalleled advantages, such as low production costs, low transport requirements for ease of transport, the ability to cross cell membranes and act directly on intracellular targets, and better tissue permeability. Therefore, small molecule drugs have an important role to play in stroke therapy. We have more than ten years of research experience in the field of small molecule drug development in stroke and have formed a unique research service system, which can provide you with scientific and comprehensive research services.

  • Stroke Drug Development Targeting Cell Death
  • Stroke Drug Development Targeting Different Cell Types
  • Stroke Drug Development Targeting Other Components

Biologics for Stroke

Biologics for Stroke

As research continues to advance and technology evolves, scientists are developing more and more biologics for the treatment of stroke. Based on our professional team and advanced technology platform, we provide comprehensive services for the development of different biologics in areas including but not limited to the development of stem cell therapies, development of gut microbiota therapies, development of therapeutic antibody therapies, development of exosome therapies, and development of UCHL1-based therapies.

  • Development of Stem Cell Therapy for Stroke
  • Stroke Drug Development Targeting Gut Microbiota
  • Development of Therapeutic Antibodies for Stroke
  • Development of Exosome-Based Stroke Therapy
  • Development of UCHL1-Based Stroke Therapy

Preclinical Drug Study Platform

Preclinical Drug Study Platform

An integrated and advanced preclinical drug study platform is a fundamental requirement to ensure the science and quality of our research services. Therefore, our scientists are always up to date and proactive in learning the latest knowledge and technology. We also keep our equipment and facilities up to date to meet the needs of different studies. In addition, we have different technical teams in different research areas to ensure the professionalism and science of our team.

  • Drug Screening Platform Services
    Small Molecules Library for Stroke Drug Discovery
  • Drug Efficacy Testing
    Behavioral Testing Services
    Biomarker Measurement Services for Stroke
    Quantitative Pharmacodynamic Analysis Services for Stroke
  • Pharmacokinetic Testing
  • Safety Evaluation Testing
  • Pharmaceutic Preparation Services

Ace Therapeutics has extensive research experience in the field of stroke drug development and our services have been validated by many parties. Once the project starts, our scientists will be in contact with you at any time to improve or optimize the project details according to your needs. If you would like to learn more about our services, please feel free to contact us.

All of our services are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
0
Inquiry Basket